Vimarsana
Biggest News Aggregation in the World

Page 31 - Evercore Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evercore Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evercore Group Today - Breaking & Trending Today

Vaxcyte Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Vimarsana News

Vaxcyte Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

SAN CARLOS, Calif., April 21, 2023 -- Vaxcyte, Inc. , a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial... | April 21, 2023

Vaxcyte : Underwriting Agreement - Form 8-K - Vimarsana News

Vaxcyte : Underwriting Agreement - Form 8-K

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ... | April 20, 2023

Ascendis Pharma A/S : Articles of Association - Form 6-K - Vimarsana News

Ascendis Pharma A/S : Articles of Association - Form 6-K

Articles of Association of Ascendis Pharma A/S Name,... | April 12, 2023

PDVSA's supervising board to appeal new creditors' move to go after Citgo - Vimarsana News

PDVSA's supervising board to appeal new creditors' move to go after Citgo

A board that supervises Venezuela's overseas assets said it plans to file an appeal to a U.S. court's decision granting four firms the right to seize shares in one of the parent companies of Venezuela-owned U.S. refiner Citgo Petroleum.

PDVSA's supervising board to appeal new creditors' move to go after Citgo - Vimarsana News

PDVSA's supervising board to appeal new creditors' move to go after Citgo

A board that supervises Venezuela's overseas assets said it plans to file an appeal to a U.S. court's decision granting four firms the right to seize shares in one of the parent companies of... | March 31, 2023